Class [10]
Medical Instrument Products
Medical equipment for genome analysis in cancer diagnostics, for the diagnosis of genomic changes and tests at the molecular level, in particular laboratory equipment for next generation sequencing (NGS), in particular laboratory equipment for next generation sequencing (NGS) in the context of clinical and medical applications, and instruments for assisting automated decisions for diagnostic and therapeutic applications; Medical equipment for pharmacological, pharmacogenetic, molecular and/or biochemical analysis of substances and medicines, in particular for the analysis of the action mechanisms of pharmaceutical preparations, in particular in the field of medicine safety and medicine compatibility, in particular laboratory equipment for high resolution and/or highly sensitive analysis; Medical equipment for toxicity research in relation to pharmaceutical preparations; Medical equipment for analysis of resistance to pharmaceutical preparations; Surgical, medical, dental and veterinary apparatus and instruments; Testing apparatus for medical applications; Surgical implants; Physical activity apparatus for medical purposes.
Class [42]
Computer & Software Services & Scientific Services
Scientific services for providing data for scientific, analytical and clinical purposes, in particular collation and systematic review of patient-specific molecular, genomic and/or clinical data, in particular in relation to changes at the genomic level, in particular in relation to changes at the genomic level in cancerous conditions; scientific clinical studies; Compilation of data for basic research and for analytical purposes, in particular compilation of mathematical and statistical data, clinical data, data relating to genome analysis of patients and data from clinical studies relating to the clinical reaction behaviour of a patient to certain medication and treatment methods; The bringing together of data for the purposes of research and analysis in the field of medical science and diagnostics, in particular the bringing together of patient-specific molecular and genomic data, in particular genomic data relating to cancer diseases; Services in the field of science, technology and research, in particular for medical purposes in the field of medical diagnostics and treatment optimisation; Scientific information and Scientific consultancy in the field of pharmaceutical side effects, genome analysis, cancer medicine, translational medicine and evaluation of cohort studies, in particular in the field of patient cohort stratification; Providing of scientific services in the field of next-generation sequencing (NGS), including analysis and interpretation of data obtained, in particular data obtained from cancer patients, in particular analysis and interpretation of genomic changes that play a part in the patient's individual condition, in particular a cancerous condition; Providing search engines for the internet comprising medical, pharmaceutical, biological and/or genetic information for medical, diagnostic, analytical and/or pharmacogenetic purposes; Providing search engines for the internet with an online search function comprising medical, pharmaceutical, biological, clinical and/or genomic information for scientific, analytical and clinical purposes; Providing search engines with an online search function in the field of analysis and development of active ingredients, cancer medicine, translational medicine, interventional epidemiology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis; Design and development of computer software in the field of biology, medicine and bioinformatics; Design and development of computer software for the integration of patient-specific data, molecular test results, clinical studies and scientific research results; Providing non-downloadable computer software for use by laboratory personnel, specialised medical personnel for medical diagnostics and treatment, in particular in the field of cancer diagnostics and therapy; Design and development of databases comprising biomarkers and biomarker data, in particular analysis of biomarkers and correlation thereof with specific disease symptoms; Providing of databases (software) with an online search function for medical, analytical and diagnostic research and clinical application, and for analysis and optimisation of treatment protocols and dose-effect curves; Software as a service (SaaS) and providing computer software for optimising the treatment of patients by extracting and correlating genomic, clinical and/or pharmacogenetic data, the creation of active ingredient protocols and clinical profiles, integration and statistical analysis of data for medical purposes; Providing of non-downloadable computer software for obtaining and for the correlation of genomic data, active ingredient protocols, clinical profiles, and for the integration and statistical analysis of data for medical diagnostics and treatment purposes; Medical and scientific research and scientific consultancy, in particular design and conducting of studies relating to medicine safety and medicine compatibility, in particular for optimisation of clinical studies in the field of cancer treatment and in the field of other disorders; Scientific consultancy in the field of medicines and genetics, in particular conducting of experiments in medicine safety and dispensing and experiments in medicine compatibility, experiments in relation to the action mechanisms of medicines, including resistance and toxicity studies, including in the field of cancer treatment for others and in the field of other disorders; Scientific consultancy and research in the field of biomarker analysis, optimisation of clinical studies, development of diagnostics, in particular in the field of active ingredient conversion, including pharmacogenetic studies; Conducting of molecular tests, in particular cancer tests based on the analysis of genomes, in particular through the application of next generation sequencing (NGS) methods; In particular the analysis of genomic changes through next generation sequencing of patient DNA.
Class [44]
Medical, Beauty & Agricultural Services
Medical services in the form of providing medical information based on analysis of collated genetic information and information relating to treatment of cancerous conditions and other diseases and health conditions; Providing medical information in the field of pharmaceutical side effects, genome analysis, cancer medicine and translational medicine; Providing online databases containing medical, pharmaceutical and genomic information; Consultancy relating to medicines and genetics with regard to medical treatment methods for individual patients, in particular in the field of clinical diagnostics and therapy, in particular in the field of cancer diagnostics and cancer therapy; Medical consultancy relating to the treatment and diagnosis of individuals in the field of clinical pharmacology and the analysis of dose-effect curves for treatment purposes; Providing pharmacological information, in particular relating to medicine safety and active ingredient compatibility in cancer therapy and the treatment of individuals; Medical consultancy in the field of patient treatment and treatment protocols; Medical tests at the molecular level and at the genome level for diagnostics and treatment purposes, in particular in cancer diagnostics and cancer therapy; Diagnostic services for cancer patients and patients with other diseases and health disorders; Collation and analysis of genetic information in connection with cancer diseases and other treatment; Medical data and information processing, storage and communication to doctors and specialised medical personnel; Providing of a medical information platform with information about cancer profiles of individual patients and changes at the genomic level that are seen with cancer, in order to enable doctors and medical specialists to optimise treatment methods in clinical practice; Providing of a medical information platform with information about action mechanisms, resistance studies and toxicity studies of active ingredients, medicines and pharmaceutical preparations, in order to enable doctors and medical specialists to optimise treatment methods in clinical practice; Providing of a medical information platform with information in the field of active ingredient conversion, in order to enable doctors and medical specialists to optimise treatment methods in clinical practice; Providing of a medical information platform with information about biomarkers and biomarker data, in order to enable doctors and medical specialists to optimise treatment methods in clinical practice.
